Background and Objective: Periodontal diseases are a major public health concern leading to tooth loss and have also been shown to be associated with several chronic systemic diseases. Smoking is a major risk factor for the development of numerous systemic diseases, as well as periodontitis. While it is clear that smokers have a significantly enhanced risk for developing periodontitis leading to tooth loss, the population varies regarding susceptibility to disease associated with smoking. This investigation focused on identifying differences in four broad sets of variables, consisting of: (i) host-response molecules; (ii) periodontal clinical parameters; (iii) antibody responses to periodontal pathogens and oral commensal bacteria; and (iv) other variables of interest, in a population of smokers with (n = 171) and without (n = 117) periodontitis.
Periodontal diseases are a major public health concern leading to tooth loss and associated chronic systemic diseases (1) (2) (3) (4) (5) (6) (7) . Bacterially induced periodontal diseases have been categorized into two general types related to connective tissue attachment loss and alveolar bone resorption (i.e. gingivitis and periodontitis). Gingivitis is a reversible inflammation of the gum tissue (i.e. gingiva) caused by the presence of a biofilm that forms on the tooth surface and resolves rather quickly after the reinstitution of mechanical and chemical oral-hygiene procedures. Most individuals will experience at least mild and transient gingivitis at some time in their life (8) (9) (10) . Periodontitis is characterized by persistent gingival inflammation, breakdown of the connective tissue (i.e. the attachment apparatus surrounding the teeth) and destruction of alveolar bone (11, 12) , with epidemiologic data supporting the concept of differential susceptibility to periodontitis regarding its onset, rate of progression and severity across the population (13, 14) .
Smoking is a major risk factor for developing numerous systemic diseases, as well as periodontitis (15) (16) (17) (18) . Smokers frequently present with lower levels of gingival bleeding than would be predicted based upon the level of tissue destruction of the periodontium (19) . This is probably a result of the effects of the smoke-derived xenobiotics on local vascular functions (19, 20) , while tobacco smoke appears to amplify the inflammatory response to the microbial challenge (21) (22) (23) . A report using data from the Third National Health and Nutrition Examination Survey (NHANES III) determined that a population-attributable risk for current or former smoking was approximately 50% for exhibiting periodontitis (24) . However, while it is clear that smokers have a significantly enhanced risk for developing periodontitis leading to tooth loss, susceptibility to disease associated with smoking varies among the population (25, 26) .
The oral ecology in an individual evolves over time, with variations in quantity and quality of phyla, genera and species (27), as well as in the genomic profile of the individual species (28) (29) (30) . However, this evolution generally leads to equilibrium between the microbiota and the individual's oral environment, as a climax community. The resulting microbial communities or biofilms are complex ecosystems of bacteria that are somewhat unique to various ecological niches in the oral cavity (31) . The microbiomes of the subgingival environment of periodontally healthy and periodontally diseased sites are quite distinct (27, 32) . The accretion of tooth-associated bacterial biofilms elicits gingival inflammation as a result of bacterial virulence and metabolic factors affecting tissue vasculature. In sites colonized by biofilms of higher pathogenicity the inflammatory response results in destruction of connective tissue and alveolar bone, the classic features of periodontitis. Various extrinsic environmental factors can also affect the microbial composition in the oral cavity, as well as hostresponse patterns. Recent studies have demonstrated clear effects of smoking on the composition of the microbiome at sites of periodontitis and periimplantitis (33) (34) (35) (36) .
The accumulation of these biofilms also elicits a robust inflammatory response, with the cellular infiltrate releasing a panoply of proinflammatory molecules that initiate clinical inflammatory measures of gingival redness and edema (14, 37, 38) . Numerous studies of gingival crevicular fluid at inflamed sites have identified associated biomolecules, such as interleukin (IL)-1b, prostaglandin E2 (PGE2), IL-10 and acute-phase response proteins, including plasminogen activator inhibitor-1 (PAI-1) and myeloperoxidase (MPO), which can contribute to local antibacterial responses (39) . The current paradigm in periodontal disease is a local chronic infection with microbial dysbiosis (40) that triggers a persistent destructive inflammatory response, rather than direct toxic/noxious actions of the bacterial virulence factors (41) . Beyond innate immune and inflammatory responses, substantial literature documents the production of specific local and systemic antibodies to oral bacteria (38) . Bacterial species-specific antibody levels increase significantly with periodontitis and decrease following therapy (14, 38) . Additionally, various studies have demonstrated alterations in the characteristics of the induced antibody in the presence of smoking (42) (43) (44) . However, there are rather limited data on these adaptive immune responses in smokers presenting with a range of periodontal health and periodontal diseases.
The present study investigates changes in magnitude of four broad sets of variables, consisting of: (i) host-response molecules; (ii) periodontal clinical parameters; (iii) antibody measures of periodontal pathogens and oral commensal bacteria; and (iv) other variables of interest related to the smoking population, with (n = 171) and without (n = 117) periodontitis. Subsequently, it investigates the potential associations and crosstalk between these variables using Bayesian network structure learning (BNSL) techniques. BNSL is a probabilistic approach and is widely used (45) (46) (47) to model direct, as well as conditional, dependencies between a given set of variables. In contrast to traditional statistical modeling, BNSL does not impose a predefined relationship between the given set of variables. Rather, it aims to discover these relationships from the data generated across the variables and abstract them as directed acyclic graphs (DAGs). The resulting DAGs can validate established associations, as well as discover novel undocumented associations, thus providing a more informed basis for hypothesis generation in addition to hypothesis testing. More importantly, a break down in associations across disease states is accompanied by marked changes in the topology or wiring pattern (48) (49) (50) 
Material and methods

Patient population and clinical parameters
The cohort (age range: 21-65 years) included 30 periodontally healthy subjects (male/female ratio: 7 : 23), 55 patients with gingivitis (male/female ratio 14 : 41) and 184 patients with periodontitis (male/female ratio 73 : 111). The protocol for this study was approved by the University of Kentucky Institutional Review Board and all participants signed an appropriate consent form. A comprehensive oral and periodontal examination was completed to assess the periodontal health of the cohort. Inclusion/exclusion criteria for participating in the study were as follows: smokers; able to complete a questionnaire and sign a consent form; have a minimum of 20 teeth; and willing to have blood drawn, whole saliva collected and have a full periodontal evaluation.
Three clinical parameters routinely used for periodontal evaluationmean probing pocket depth, clinical attachment level (51) and bleeding on probing -were assessed in all patients. Full-mouth mean pocket depth and attachment level were measured in millimeters, and bleeding on probing, measured as the percentage of sites in the mouth that bleed, was determined at six sites per tooth, excluding third molars (52) . The measurements were taken and recorded by a single examiner. Measures of bleeding on probing and probing pocket depth were used to categorize the patients, recognizing that various patients fell into 'gray' areas. These 'gray' area patients were assigned to a category and simply contributed to the variation within the different groups. We used a mean probing pocket depth of ≤ 2.5 mm for nonperiodontitis (i.e. health and gingivitis) and a mean probing pocket depth of > 2.5 mm for periodontitis. While all subjects with gingivitis were categorized accurately (> 20% sites with bleeding on probing; mean probing pocket depth of ≤ 2.5 mm), a subset of 26 healthy subjects had a mean probing pocket depth of > 2.5 mm but a limited percentage of bleeding on probing and no sites with pocket depths of > 4 mm. Two of the subjects with periodontitis had a mean probing pocket depth of ≤ 2.5 mm, but these subjects also had a high percentage of bleeding on probing and numerous sites with pocket depths of > 4 mm.
Variables such as age, pack years of smoking, salivary cotinine levels and body mass index, which have been traditionally investigated in periodontitis and smoking population studies, were also included in the analysis.
Serum analyses
Serum from a venipuncture blood sample was originally obtained from a group of 301 smokers (21-65 years; 82 Black and 219 White; 106 men and 195 women). After preliminary investigation and elimination of missing values (n = 13 excluded), the subjects were distributed into nonperiodontitis (NP; n = 117) and periodontitis (PD; n = 171) groups. The serum samples were stored at À80°C until the assays were performed. An array of oral microorganisms was used in the assays, cultivated under standard conditions and prepared for antigens as described previously (53) . The bacteria included periodontal pathogens: Aggregatibacter actinomycetemcomitans strain JP2; Porphyromonas gingivalis (ATCC 33277); Treponema denticola (ATCC 35405); and a group of oral commensal bacteria that included Streptococcus sanguinis (ATCC 10556), Actinomyces naeslundii (ATCC 49340), Veillonella parvula (ATCC 10790) and Capnocytophaga ochracea (ATCC 33596). An ELISA was used to determine the levels of IgG to the bacteria (52). Purified human IgG was bound to the ELISA plate, and the wells developed with the same anti-human IgG reagents as the bacterial antigen coated wells to produce a standard curve. Sample data were extrapolated from this curve, using a four-parameter logistic curve fit (54) . Molecular markers of inflammatory responses in serum, including IL-1b, PAI-1, MPO and IL-10, were evaluated using Luminex beadlyte technology (EMD Millipore, Billerica, MA, USA) or commercial high-sensitivity PGE 2 ELISA kits (Assay Design, Ann Arbor, MI, USA) (42) .
Salivary cotinine levels were measured in whole saliva using an ELISA (Salimetrics' High Sensitivity Salivary Cotinine Quantitative enzyme immunoassay kit; Salimetrics Biotechnology Co., State College, PA, USA), as described previously (43) .
Statistical analyses
The parametric t-test was used to identify those variables whose magnitude changed significantly across NP and PD groups after controlling the false-discovery rate (55) . Variables for which the adjusted p-values were significant (p < 0.02) are reported. Subsequently, BNSL was used to model potential associations between 15 variables, comprising critical proteins (IL-1b and PAI-1), clinical parameters (bleeding on probing, probing pocket depth and clinical attachment level), antibody to periodontal pathogens (A. actinomycetemcomitans, P. gingivalis and T. denticola) and oral commensal bacteria (C. ochrace, A naeslundii, V. parvula and S. sanguinis), and other variables (age, pack years of smoking and salivary cotinine levels) across subjects in PD and NP groups in the smoking population. Several techniques, such as constraintbased and search-score approaches, have been traditionally proposed in the literature for BNSL (56) (57) (58) . Recent studies have shown that hybrid techniques, such as max-min hill climbing (MMHC), which use a combination of constraint-based and search-score frameworks in tandem, outperform both constraint-based and search-score approaches (59) . The constraint-based part of MMHC uses a max-min parents-children approach to determine the skeleton of the underlying network. Subsequently, a Bayesian-greedy hill-climbing approach is used to determine the orientation of the edges in the skeleton. PDAG representations that incorporate equivalence classes of the DAGs were subsequently generated (56, 57) to account for DAGs that are probabilistically indistinguishable. Confidence of the edges (60, 61) in the PDAGs was determined from 1000 independently by resampling with replacement, and edges with confidence less than 30% were deemed noisy and hence were eliminated from further consideration. The remaining edges, along with their confidences, are reported as weighted graphs. Open-source implementation of the MMHC approach as part of the bnlearn R package (62, 63) was used in the present study. Graphical layouts were generated using Gephi (64) .
Results
Adjusted p-values (p < 0.02) from a parametric t-test after controlling the false-discovery rate (55) revealed eight variables that exhibited a marked difference between the PD and NP groups ( Table 1) . As expected, the three clinical parameters (bleeding on probing, probing pocket depth and clinical attachment level) were significantly elevated in the PD group compared with the NP group. As the groups were defined by clinical parameters, it was expected that these would be significantly different. Of the remaining variables, IL-1b, PAI-1, pack years of smoking and antibody to P. gingivalis and A. naeslundii were also significantly elevated in the PD group. As previous results had not evaluated variations in host responses across clinical presentation in smokers, alterations in targeted inflammatory mediators and antibody levels, particularly to P. gingivalis, were undefined previously, but were not totally unexpected.
Subsequently, the MMHC approach was used to generate the Bayesian networks representing the interplay between 15 clinical and host-response variables across the NP and PD smoking population. Confidence of the edges in the network was generated across 1000 independent bootstrap realizations. The four sets of variables are shown by distinct colors in Fig. 1A , B for clarity and the thickness of the edges is proportional to their confidence represented in these figures. Edges whose confidences were < 30% were deemed noisy, and hence are not reported. The networks corresponding to NP and PD exhibit two broad communities, revealing intricate associations and cross-talk between clinical parameters and other variables (Community 1) and among antibacterial responses (Community 2). However, there were substantial differences in the wiring pattern between them. Confidence of the edges showed marked variations within and between the NP and PD groups. While the network corresponding to the NP group is disconnected (Fig. 1A) , that of the PD group is weakly connected (i.e. it is possible to traverse between any two variables in the underlying undirected graph) (Fig. 1B) .
More importantly, in the case of the PD group, antibody to P. gingivalis seems to act as a mediator establishing an association between otherwise unrelated variables (e.g. clinical attachment level and A. actinomycetemcomitans) and in turn establishing potential associations between the parameters of Community 1 and Community 2. Unlike the PD group, there were no apparent relationships between bleeding on probing and mean probing pocket depth in the NP group. Scatter plots of percentage bleeding on probing vs. probing pocket depth also validated these findings, showing the absence of a significant direct association in the NP group (r = À0.15) as opposed to the PD group (r = 0.58, p < 0.01) ( Fig. 2A) . Our analysis also revealed some of the associations to be preserved across the NP and PD groups. This includes the correlation between antibody to the pathogen (A. actinomycetemcomitans) and to the commensal bacterium (C. chracea) being reflected by prominent edges (Fig. 1A,B) . Aggregatibacter actinomycetemcomitans and C. ochracea also exhibited a significant direct association across the NP group (r = 0.58, p < 0.01) as well as the PD group (r = 0.49, p < 0.01) (Fig. 2A) . Associations between C. ochracea and T. denticola were significant across NP (r = 0.67, p < 0.01) and PD (r = 0.61, p < 0.01) groups. Associations between C. ochracea and P. gingivalis were also significant across NP (r = 0.63, p < 0.01) and PD (r = 0.39, p < 0.01) groups (Fig. 2B) .
Examining the associations of systemic inflammatory mediators with the clinical parameters in the population of smokers also provided an interesting profile. While numerous inflammatory biomarkers have been identified in serum and related to the extent and severity of periodontitis (23, 38, 65) , the findings of this study in smokers provide a somewhat different outcome. Confidence of the edges corresponding to IL-1b and PAI-1 was markedly higher in the PD group than in the NP group, reflected by the discrepancy in the thickness of the edges in Fig. 1A ,B. This was also shown by the marked decrease in the magnitude of the Pearson correlation between IL-1b and PAI-1 from the PD group (r = 0.34, p < 0.01) compared with that of the NP group (r = 0.20, p = 0.03). Also, IL-1b was associated with the clinical parameter, mean clinical attachment level, in the NP group (Fig. 1A) , whereas it was connected to the host-response variables through linkage with antibody to the pathogen T. denticola in the PD group (Fig. 1B) . Also, the markers IL-1b and PAI-1 did not exhibit a direct association with clinical disease parameters or smoking measures in the PD group. These results suggest that smoking may disrupt control of local and systemic inflammatory responses that are related to the health of the periodontium. Active smoking (i.e. salivary cotinine levels) exhibited a strong association with the clinical parameter, clinical attachment level (p < 0.01) in the NP group ( Fig. 1A) , unlike in the PD group. While obesity has been reported to be linked to expression of periodontitis in humans (66) (67) (68) (69) (70) , our data from a population of individuals, who were all smokers, found that body mass index was not significantly associated with any of the clinical parameters, inflammatory responses or specific antibody in individuals from either PD or NP groups, and hence this parameter is not included in Fig. 1A , B. These observations may indicate that certain biologic effects of smoking could overwhelm any contribution that modifiers elicited by overweight/ obesity might have in altering the presentation of this oral disease. MPO and PGE2 exhibited a significant association across NP (r = 0.50, p < 0.01) and PD (r = 0.37, p < 0.01) groups, solely based on the correlation coefficients and associated pvalues. However, as seen with the scatter plots (Fig. 3) , the relationship has a high level of noise, suggesting that the correlations may primarily reflect outlier values of a few subjects in the groups and hence are not identified as important contributors to the community relationships identified in Fig. 1A , B. Additional variables demonstrated minimal or no relationship to these community linkages and are also not presented in the figure.
Discussion
Smoking is one, if not the major, cause of preventable morbidity and mortality in the population, and has substantial negative effects on general and oral health (16) (17) (18) 71) . Smoking has been clearly delineated as a major modifiable environmental risk factor in the extent/severity of periodontal disease through cross-sectional and longitudinal epidemiologic investigations (72) . These data indicate that there is a 300-600% increase in the incidence of periodontitis in smokers compared with nonsmokers (73), and there is clearly a deleterious impact of the wide array of xenobiotics derived from smoking on the response to periodontal therapy (16, 74) . Nevertheless, while a significantly enhanced proportion of smokers exhibit periodontitis compared with the nonsmoking population, clinical evaluations of smoking and periodontitis demonstrate that a proportion of the smoking population remains periodontally healthy or only develops gingivitis (75) . Another facet of the broader literature was that a subset of smokers appeared periodontally healthy, even with long-term smoking (i.e. pack years) and high continine levels. Thus, some features of either the microbial challenge or characteristics of the host-response profile appear to afford these patients an enhanced capacity to retain tissue homeostasis in the oral cavity. Similar observations have been summarized in a recent report by Genco and Borgnakke (69) . We have previously demonstrated serum antibody levels to selected oral pathogens and commensal bacteria in relation to race/ethnicity, age and periodontal disease extent, in a population of smokers (43) , as well as systemic inflammatory responses relative to smoking level (42) . This study extends these findings by examining both serum antibodies and inflammatory molecules in relation to smoking parameters and the periodontal condition, to identify the impact of active smoking on the relationships among these various parameters. Serum levels of IL-1b were significantly elevated in patients with periodontitis. IL-1b has been identified as a crucial molecule in chronic inflammatory responses, both locally and systemically (76, 77, 78) . This proinflammatory mediator and bone-resorbing cytokine appears to contribute to the expression of periodontitis and has been linked to serum levels of C-reactive protein and altered IL-6 production, appearing to play a role in periodontitis in type 2 diabetes mellitus (79) . Our findings in smokers with periodontitis with the highest cotinine levels and demonstrating elevated serum IL-1b provide additional data to support the importance of this proinflammatory mediator in periodontitis.
A number of proinflammatory mediators are derived via the arachidonic acid pathway, including PGE2 (80), which has been implicated in the pathogenesis of gingival inflammation and periodontitis (81, 82) . Additional biomarkers of inflammatory responses in the systemic circulation are components of the acute-phase response (e.g. PAI-1) (39) . This array of molecules serves a range of functions, with the goal of re-establishing systemic homeostasis following noxious challenge, and has been related to periodontitis, periodontal therapy and other chronic inflammatory diseases (83) (84) (85) (86) (87) (88) (89) (90) (91) . Also during the chronic inflammatory response, reactive oxygen species and free radicals (e.g. nitric oxide and nitrogen dioxide) are generated by neutrophils and macrophages, often through the action of MPO that is released into extracellular fluid at sites of inflammatory lesions (92, 93) and is affected by smoking (94, 95) . Alterations in MPO have been identified to vary in patients with periodontitis, with/without treatment (86, 96, 97, 98, 99) .
Serum IgG levels to a group of putative periodontal pathogens and oral commensal bacteria were also evaluated. As expected, antibody levels to the periodontal pathogens were significantly elevated in smokers with periodontitis and were significantly decreased in the periodontally healthy smokers. Substantial literature has demonstrated local and systemic adaptive immune responses to oral bacteria that are related to the presence, extent/severity and therapeutic outcomes of periodontitis (38, 44, 51) . We have found similar types of response differences in smokers that are related to the oral health of the individual; however, we extended the available literature by demonstrating a racial/ethnic contribution to these responses, as well as a difference in response profile to pathogenic compared with commensal oral bacteria (43) as, importantly, the level of serum antibody to oral bacteria has been shown to provide some indication of the presence and burden of the particular microorganism within the oral cavity (100, 101) . Thus, this measure is somewhat of a surrogate for oral colonization and could be suggested to reflect a challenge that the host sees as potentially deleterious and needs to be managed (100, 101) . In this regard, such a situation would be the identification of antibody to A. actinomycetemcomitans interfacing with responses to P. gingivalis and T. denticola in the nonperiodontitis smokers and also linked to clinical parameters in the periodontitis subset. Historically, periodontitis has been categorized as chronic adult and aggressive (102) and linked to microbiological characteristics with P. gingivalis and A. actinomycetemcomitans, which are generally considered as representative of the major pathogens in these diseases (38, 103, 104) . The majority of these studies intermixed both smokers and nonsmokers in their cohorts, and did often identify various clinical and biological differences related to smoking. However, our population, comprised entirely of smokers, presented a somewhat unique profile. In the NP group, antibody levels to P. gingivalis and A. actinomycetemcomitans were associated with antibody to an important commensal species, C. ochracea, albeit the level of antibody to these bacteria was significantly lower than in the PD group, as expected (38, 43) . Interestingly, in the PD group, antibody to C. ochracea, generally reflecting microbial challenge, was associated with the group of commensal bacteria and provided a strong link to responses to the oral pathogens (i.e. A. actinomycetemcomitans, P. gingivalis and T. denticola). This host response identifying these members of the microbial ecolody was also uniquely related to the community of variables that included the clinical and smoking parameters via responses to P. gingivalis. Thus, in patients with periodontitis, in whom P. gingivalis represents a hallmark bacterial species and has been proposed as a keystone pathogen, the relationships in this smoking population reflected the capacity of P. gingivalis to interface clinical disease with a range of host responses.
These differences in responses were also obvious in demonstrating significant correlations of serum PGE2, IL1b and PAI-1 with various smoking parameters. In contrast, the serum antibodies lacked this type of relationship. We subsequently examined the direct relationship between the individual serum inflammatory mediators and the adaptive immune responses in subsets of patients stratified according to salivary cotinine levels. The results demonstrated that in the subsets with lower cotinine levels, antibodies to a number of the commensal bacteria were significantly negatively correlated with serum PGE2 and MPO levels. In contrast, in subsets with high cotinine levels, antibody levels to pathogens, particularly to P. gingivalis, were significantly positively correlated with some of the inflammatory mediators (42) . Thus, while antibodies were not directly correlated with cotinine and smoking levels, there appeared to be some interface between the systemic inflammatory and adaptive responses that was related to the interactions of smoking and periodontal disease.
The present study investigated variations in the magnitude of expression of four broad categories of variables between periodontitis and nonperiodontitis smoking populations. Subsequently, potential cross-talk and associations between these variables were investigated using a BNSL. In contrast to traditional statistical modeling, BNSL does not impose any constraint on the associations between the variables; rather, it discovers direct as well as indirect associations from the given data. This aspect of BNSL is especially useful in hypothesis generation. BNSL accommodates all the variables simultaneously and has the ability to provide system-level insights and potential cross-talk between them; thus, BNSL is markedly different from traditional reductionist approaches that investigate only subsets of variables in isolation. More importantly, BNSL has the ability to validate established associations, such as P. gingivalis responses in periodontitis, and the relationship between age and/or amount of smoking and clinical measures of periodontal disease. Additionally, this approach can help to ascertain novel associations with minimal precedence, such as the relationship of select inflammatory mediators with clinical presentation on nonperiodontitis smokers, inflammatory mediators linked more strongly to the microbial challenge in periodontitis, the centrality of the response to C. ochracea with response profiles to both commensals and pathogens and the apparent ability of P. gingivalis to provide a bridge in linking bacterial responses to clinical parameters of disease in the subset of smokers with periodontitis. More importantly, the results revealed marked variation in associations, their confidence, as well as in the overall network topology between the PD and NP groups. It remains to be determined whether there are molecules in the xenobiotic mix of smoking products that trigger unique host-response profiles or if this relationship reflects a general noxious challenge to host tissues and cells that results in some specificity for eliciting the inflammatory and adaptive responses. Thus, while periodontitis is considered to reflect a dysregulated host response to subgingival biofilms, these data suggest that smoking has the capacity to disrupt these responses to an even greater degree, thus increasing the risk for disease initiation/progression.
